VORICONAZOLE FOR INJECTION

USDailyMed:Voriconazole AU:B3 J02AC03(WHO) AU:S4(Prescription only)CA:℞-onlyUS:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only) (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 137234-62-9Y 71616 DB00582Y 64684Y JFU09I87TR D00578Y CHEBI:10023Y ChEMBL638Y DTXSID5046485 Interactive image Fc1cncnc1[C@@H]([C@@](O)(c2ccc(F)cc2F)Cn3ncnc3)C InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1YKey:BCEHBSKCWLPMDN-MGPLVRAMSA-NY Voriconazole, sold under the brand nameVfendamong others, is anantifungal medicationused to treat a number offungal infections.This includesaspergillosis,candidiasis,coccidioidomycosis,histoplasmosis,penicilliosis, and infections byScedosporiumorFusarium.It can be takenby mouthor used byinjection into a vein. Common side effects include vision problems, nausea, abdominal pain, rash, headache, andhallucinations.Use duringpregnancymay result in harm to the fetus.It is in thetriazolefamily of medications.,and works by affecting fungal metabolism and fungalcell membranes. Voriconazole was patented in 1990 and approved for medical use in the United States in 2002.It is on theWorld Health Organization's List of Essential Medicines.